Consequently, self-tumor Ag-specific CD8+ T cells have a higher chance of being activated and proliferated under lymphopenic rather than non-lymphopenic conditions, which can be further enhanced by IL7-Fc. The gene discussed is CD8A; the disease is neoplasm.